U.S. Markets closed

ConMed, Activist Go Down to the Wire in Proxy Fight


A proxy fight is looming at medical device company ConMed. But in this day of increased shareholder activism the fight to get board seats is unusual. There's already an activist--Coppersmith Capital--with seats on the board that oversaw the retirement of the company's CEO and founder and the appointment of an interim CEO. But the new dissident, Voce Capital, founded by Daniel Plants, is not only unhappy with ConMed's progress in turning itself around, industry sources tell The Deal's Ron Orol that the firm isn't happy with ConMed's strategic review that it just closed without naming a buyer.